ATE333502T1 - Verfahren zur herstellung von nukleinsäure- und polypeptidbanken durch in vivo rekombination und ihre verwendungen - Google Patents
Verfahren zur herstellung von nukleinsäure- und polypeptidbanken durch in vivo rekombination und ihre verwendungenInfo
- Publication number
- ATE333502T1 ATE333502T1 AT99972677T AT99972677T ATE333502T1 AT E333502 T1 ATE333502 T1 AT E333502T1 AT 99972677 T AT99972677 T AT 99972677T AT 99972677 T AT99972677 T AT 99972677T AT E333502 T1 ATE333502 T1 AT E333502T1
- Authority
- AT
- Austria
- Prior art keywords
- nucleic acid
- recombination
- polypeptide
- methods
- replication
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title abstract 9
- 108020004707 nucleic acids Proteins 0.000 title abstract 7
- 102000039446 nucleic acids Human genes 0.000 title abstract 7
- 238000005215 recombination Methods 0.000 title abstract 6
- 230000006798 recombination Effects 0.000 title abstract 6
- 229920001184 polypeptide Polymers 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 102000018120 Recombinases Human genes 0.000 abstract 2
- 108010091086 Recombinases Proteins 0.000 abstract 2
- 230000010076 replication Effects 0.000 abstract 2
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Ceramic Products (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1998MI002509A IT1303776B1 (it) | 1998-11-19 | 1998-11-19 | Processo per la preparazione di genoteche, di polipeptidi utilizzandodette genoteche e i polipepti ottenuti. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE333502T1 true ATE333502T1 (de) | 2006-08-15 |
Family
ID=11381090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99972677T ATE333502T1 (de) | 1998-11-19 | 1999-11-18 | Verfahren zur herstellung von nukleinsäure- und polypeptidbanken durch in vivo rekombination und ihre verwendungen |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1131421B1 (de) |
| AT (1) | ATE333502T1 (de) |
| AU (1) | AU3790300A (de) |
| CA (1) | CA2350779A1 (de) |
| DE (1) | DE69932446T2 (de) |
| ES (1) | ES2268907T3 (de) |
| IL (2) | IL143123A0 (de) |
| IT (1) | IT1303776B1 (de) |
| WO (1) | WO2000031246A2 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6780620B1 (en) | 1998-12-23 | 2004-08-24 | Bristol-Myers Squibb Company | Microbial transformation method for the preparation of an epothilone |
| US6686154B2 (en) | 2000-06-05 | 2004-02-03 | Zyomyx, Inc. | Screening of phage displayed peptides without clearing of the cell culture |
| DE60224720D1 (en) * | 2001-11-22 | 2008-03-06 | Univ Keio | Re |
| EP2566512A1 (de) | 2010-05-04 | 2013-03-13 | Merrimack Pharmaceuticals, Inc. | Antikörper gegen den epidermalen wachstumsfaktorrezeptor (egfr) und ihre verwendung |
| US8691231B2 (en) | 2011-06-03 | 2014-04-08 | Merrimack Pharmaceuticals, Inc. | Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies |
| WO2013173582A1 (en) | 2012-05-17 | 2013-11-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Hepatitis c virus neutralizing antibody |
| WO2014065822A1 (en) | 2012-10-26 | 2014-05-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Hepatitis c virus neutralizing epitopes, antibodies, and methods |
| US20180244785A1 (en) | 2017-01-09 | 2018-08-30 | Merrimack Pharmaceuticals, Inc. | Anti-fgfr antibodies and methods of use |
| TWI788340B (zh) | 2017-04-07 | 2023-01-01 | 美商必治妥美雅史谷比公司 | 抗icos促效劑抗體及其用途 |
| EP3694552A1 (de) | 2017-10-10 | 2020-08-19 | Tilos Therapeutics, Inc. | Anti-lap-antikörper und verwendungen davon |
| US20210371537A1 (en) | 2018-09-18 | 2021-12-02 | Merrimack Pharmaceuticals, Inc. | Anti-tnfr2 antibodies and uses thereof |
| US11130802B2 (en) | 2018-10-10 | 2021-09-28 | Tilos Therapeutics, Inc. | Anti-lap antibody variants |
| WO2020084034A1 (en) | 2018-10-26 | 2020-04-30 | F. Hoffmann-La Roche Ag | Multispecific antibody screening method using recombinase mediated cassette exchange |
| CA3131953A1 (en) | 2019-03-01 | 2020-09-10 | Merrimack Pharmaceuticals, Inc. | Anti-tnfr2 antibodies and uses thereof |
| CA3130546A1 (en) | 2019-03-29 | 2020-10-08 | Tilman Schlothauer | Method for the generation of an fcrn expressing cell by targeted integration of multiple expression cassettes in a defined organization |
| EP4129332A4 (de) * | 2020-03-27 | 2024-04-24 | Ddbio. Co, Ltd., (Shang Hai) | Verfahren zur anzeige eines bispezifischen antikörpers auf der oberfläche einer säugerzelle und vektor |
| EP4132971A1 (de) | 2020-04-09 | 2023-02-15 | Merck Sharp & Dohme LLC | Affinitätsgereifte anti-lap-antikörper und verwendungen davon |
| CN117430696A (zh) * | 2022-07-22 | 2024-01-23 | 北京智仁美博生物科技有限公司 | 用于表达Fab片段库的重组系统 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6117679A (en) * | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US5728557A (en) * | 1995-06-01 | 1998-03-17 | Merck & Co., Inc. | Method of making herpes simplex type 1 mutants and mutants so produced |
| WO1998028416A1 (en) * | 1996-12-20 | 1998-07-02 | Novo Nordisk A/S | In vivo recombination |
-
1998
- 1998-11-19 IT IT1998MI002509A patent/IT1303776B1/it active
-
1999
- 1999-11-18 DE DE69932446T patent/DE69932446T2/de not_active Expired - Lifetime
- 1999-11-18 IL IL14312399A patent/IL143123A0/xx unknown
- 1999-11-18 WO PCT/EP1999/008856 patent/WO2000031246A2/en not_active Ceased
- 1999-11-18 AU AU37903/00A patent/AU3790300A/en not_active Abandoned
- 1999-11-18 CA CA002350779A patent/CA2350779A1/en not_active Abandoned
- 1999-11-18 AT AT99972677T patent/ATE333502T1/de not_active IP Right Cessation
- 1999-11-18 ES ES99972677T patent/ES2268907T3/es not_active Expired - Lifetime
- 1999-11-18 EP EP99972677A patent/EP1131421B1/de not_active Expired - Lifetime
-
2001
- 2001-05-14 IL IL143123A patent/IL143123A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL143123A (en) | 2009-11-18 |
| DE69932446T2 (de) | 2007-01-04 |
| WO2000031246A2 (en) | 2000-06-02 |
| IT1303776B1 (it) | 2001-02-23 |
| IL143123A0 (en) | 2002-04-21 |
| WO2000031246A3 (en) | 2000-08-17 |
| ES2268907T3 (es) | 2007-03-16 |
| EP1131421A2 (de) | 2001-09-12 |
| DE69932446D1 (de) | 2006-08-31 |
| EP1131421B1 (de) | 2006-07-19 |
| ITMI982509A1 (it) | 2000-05-19 |
| AU3790300A (en) | 2000-06-13 |
| CA2350779A1 (en) | 2000-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE333502T1 (de) | Verfahren zur herstellung von nukleinsäure- und polypeptidbanken durch in vivo rekombination und ihre verwendungen | |
| ATE460472T1 (de) | Verfahren und zusammensetzungen zur synthese von nukleinsäuremolekülen unter verwendung multipler erkennungsstellen | |
| ATE294229T1 (de) | Verfahren zur trocknung von kompetenten zellen | |
| DE69427997D1 (de) | Hybrider mensch/tier faktor viii | |
| ATE391789T1 (de) | Verwendung einer vielzahl von rekombinationsstellen mit einzigartiger spezifität beim rekombinatorischen klonen | |
| FI925986A0 (fi) | Slumpartat bio-oligomer bibliotek, ett foerfarande foer syntetisering avdet samt ett foerfarande foer anvaendning av det | |
| DE59708838D1 (de) | Spiegelselektion und spiegelevolution von nucleinsäuren | |
| ATE449850T1 (de) | Mutanten von flt3-l und ihre verwendungen | |
| DE69833698D1 (de) | Verfahren zur Herstellung von Arrays hoher Dichte | |
| DK0586618T3 (da) | Anvendelse af nuklainsyreanaloger i diagnostiske og analytiske fremgangsmåder | |
| ATE425175T1 (de) | Verfahren und zusammensetzungen zur bestimmung von sequenzen von nukleinsäure-molekülen | |
| DE69928263D1 (de) | Verfahren zur herstellung in vitro von rekombinierten nucleotidsequenzen, und so hergestelte genbanken und sequenzen | |
| DE69821376D1 (de) | Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht | |
| AU2002218166A1 (en) | Collections of repeat proteins comprising repeat modules | |
| ES2166371T3 (es) | Celulas de levadura tratadas para producir sustitutos de proteinas de sistemas de feromonas y usos de las mismas. | |
| ATE278024T1 (de) | Methode zur herstellung von rekombinanten zellen | |
| ATE317899T1 (de) | Gefrierschutzproteine aus choristoneura sp., gene und verfahren zu ihrer verwendung | |
| ATE279441T1 (de) | Verfahren zur herstellung von genetisch veränderten lymphozyten vorläuferzellen von wirbeltieren und deren gebrauch zur produktion von heterologen bindeproteinen | |
| DK1098991T3 (da) | Hidtil ukendte fremgangsmåder til identifikation af ligand- og målbiomolekyler | |
| DE60233347D1 (de) | Schnellreifende fluoreszierende proteine und verfahren zu deren anwendung | |
| ATE522604T1 (de) | Verfahren zur herstellung von proteinen durch elektropulsierung | |
| ATE383575T1 (de) | Verfahren zur herstellung einer normalisierten genbank aus nukleinsäure-exktrakten von bodenproben und deren verwendung | |
| WO1998042868A3 (en) | Screening method for proline-rich proteins | |
| Amato | A high-flying fix for ozone loss | |
| DE60334087D1 (de) | Neue fluoreszierende proteine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |